Jordan Da Silva
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CT26.MtC3, a new preclinical model to investigate immune resistance in metastatic colorectal cancer.
CT26.MtC3, a new preclinical model to investigate immune resistance in metastatic colorectal cancer.
Journal: Cancer cell international
Published: September 19, 2025
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 08, 2025
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.
Journal: Journal of nanobiotechnology
Published: June 07, 2024
Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 05, 2023
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
Journal: Frontiers in immunology
Published: August 18, 2022
Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire.
Journal: Cancer cell international
Published: March 23, 2022
FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.
Journal: The Journal of pathology
Published: October 07, 2019
Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA.
Journal: British journal of cancer
Published: May 30, 2018
Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine.
Journal: Oncotarget
Published: November 16, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026